Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sustainable Development01:43

Sustainable Development

14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
Microorganisms in Agriculture and Food industry01:27

Microorganisms in Agriculture and Food industry

1.4K
Microorganisms play a crucial role in agriculture and the food industry, contributing to soil fertility, crop protection, and food production. Their functions range from nitrogen fixation and biopesticide production to fermentation and food preservation, making them indispensable to sustainable farming and food safety.Role in AgricultureNitrogen-fixing bacteria, such as Rhizobium (symbiotic) and Azotobacter (free-living), convert atmospheric nitrogen into ammonia through biological nitrogen...
1.4K
Avoidance Learning and Learned Helplessness01:14

Avoidance Learning and Learned Helplessness

2.5K
Avoidance learning and learned helplessness are critical concepts in understanding behavioral responses to negative stimuli.
Avoidance learning occurs when an organism learns that a specific behavior can prevent an unpleasant outcome. For example, a student who receives a bad grade may start studying harder to avoid future poor grades. This behavior persists even when the negative outcome is no longer present. Avoidance learning is powerful because it maintains behavior in the absence of the...
2.5K
Continuing Care01:25

Continuing Care

1.9K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K
Continuity Equation01:28

Continuity Equation

3.3K
The continuity equation asserts that the mass flow rate must remain constant for a steady flow of an incompressible fluid within a confined system. This principle applies to systems where fluid passes through varying cross-sectional areas, such as nozzles, syringes, and pipes.
The mass flow rate is expressed as:
3.3K
Continuity Equation01:20

Continuity Equation

1.5K
The total amount of current flowing per unit cross-sectional area is called the current density. Hence, the current passing through a cross-sectional area can be written as the surface integral of the current density.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Reported Health-Related Quality of Life (HRQoL) in Adults With Urea Cycle Disorders.

Journal of inherited metabolic disease·2026
Same author

Pyridoxine-dependent epilepsy: Current perspectives and questions for future research.

Annals of the Child Neurology Society·2025
Same author

Non-Hispanic Black Individuals Have Higher Glucose-Adjusted HbA1c Levels and Risk for Severe Hypoglycemia: Evidence From the Diabetes Control and Complications Trial.

Diabetes care·2024
Same author

Can HbA1c Alone Be Safely Used to Guide Insulin Therapy in African Youth with Type 1 Diabetes?

Pediatric diabetes·2024
Same author

Firearm Deaths among Youth in the United States, 2007-2016.

Children (Basel, Switzerland)·2023
Same author

Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.

The Journal of clinical endocrinology and metabolism·2023

Related Experiment Video

Updated: Jan 21, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K

Developing interactions with industry in rare diseases: lessons learned and continuing challenges.

Susan A Berry1, Curtis R Coughlin2, Shawn McCandless2

  • 1Division of Genetics and Metabolism, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA. berry002@umn.edu.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|July 25, 2019
PubMed
Summary
This summary is machine-generated.

The Urea Cycle Disorders Consortium (UCDC) fosters industry partnerships to accelerate rare disease therapeutics. Establishing a framework for collaboration aids in developing breakthrough treatments for urea cycle disorders (UCDs).

Keywords:
pharmaceuticalsprinciplesrare diseasestherapeuticsurea cycle disorders

More Related Videos

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.0K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

4.0K

Related Experiment Videos

Last Updated: Jan 21, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.0K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

4.0K

Area of Science:

  • Rare Diseases Research
  • Clinical Consortia
  • Therapeutic Development

Background:

  • The National Institutes of Health (NIH) Rare Diseases Clinical Research Network supports research on rare diseases.
  • The Urea Cycle Disorders Consortium (UCDC) is a key NIH-funded network focused on urea cycle disorders (UCDs).
  • Biopharmaceutical companies show interest in consortia like UCDC due to valuable longitudinal data and Orphan Drug Act incentives.

Purpose of the Study:

  • To describe the UCDC's experience in evaluating and establishing partnerships with private biopharmaceutical entities.
  • To outline the development of policies, procedures, and an Industry Relations Committee for industry collaborations.
  • To identify challenges and propose solutions for successful industry engagement in rare disease research.

Main Methods:

  • Review of early industry interactions and partnership frameworks.
  • Development of guiding principles for an Industry Relations Committee.
  • Analysis of challenges during therapeutic development and product approval transitions.

Main Results:

  • UCDC has established a framework for evaluating and engaging with industry partners.
  • An Industry Relations Committee with guiding principles has been formed.
  • Challenges in industry partnerships, especially post-approval, have been identified and potential solutions discussed.

Conclusions:

  • A structured framework for industry partnerships is crucial for rare disease research consortia.
  • Effective collaboration can accelerate the development of novel therapeutics for urea cycle disorders.
  • Proactive management of challenges can lead to breakthroughs in patient treatment.